NEPHROS, INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
NEPHROS, INC. (NEPH) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$169.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-05-09
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$169.00K.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$654.00K.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was -$182.00K.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$433.00K.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$1.57M.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$7.12M.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$3.88M.
- NEPHROS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$4.52M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -$169.00K 10-Q · filed 2024-05-09 | -$823.00K derived: sum of 2 quarters · filed 2024-05-09 | -$1.00M derived: sum of 3 quarters · filed 2024-05-09 | -$1.44M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-12-31 | -$654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$836.00K derived: sum of 2 quarters · filed 2024-03-15 | -$1.27M derived: sum of 3 quarters · filed 2024-03-15 | -$1.57M 10-K · filed 2024-03-15 | ||||
| 2023-09-30 | -$182.00K 10-Q · filed 2023-11-08 | -$615.00K derived: sum of 2 quarters · filed 2023-11-08 | -$921.00K 10-Q · filed 2023-11-08 | -$1.78M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-06-30 | -$433.00K 10-Q · filed 2023-08-09 | -$739.00K 10-Q · filed 2023-08-09 | -$1.60M derived: sum of 3 quarters · filed 2024-05-09 | -$4.75M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-03-31 | -$306.00K 10-Q · filed 2024-05-09 | -$1.17M derived: sum of 2 quarters · filed 2024-05-09 | -$4.32M derived: sum of 3 quarters · filed 2024-05-09 | -$5.46M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$4.01M derived: sum of 2 quarters · filed 2024-03-15 | -$5.15M derived: sum of 3 quarters · filed 2024-03-15 | -$7.12M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$3.15M 10-Q · filed 2023-11-08 | -$4.29M derived: sum of 2 quarters · filed 2023-11-08 | -$6.26M 10-Q · filed 2023-11-08 | -$7.30M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$1.14M 10-Q · filed 2023-08-09 | -$3.11M 10-Q · filed 2023-08-09 | -$4.15M derived: sum of 3 quarters · filed 2023-08-09 | -$5.32M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$1.97M 10-Q · filed 2023-05-10 | -$3.01M derived: sum of 2 quarters · filed 2023-05-10 | -$4.18M derived: sum of 3 quarters · filed 2023-05-10 | -$5.30M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$2.21M derived: sum of 2 quarters · filed 2023-03-23 | -$3.33M derived: sum of 3 quarters · filed 2023-03-23 | -$3.88M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$1.17M 10-Q · filed 2022-11-15 | -$2.29M derived: sum of 2 quarters · filed 2022-11-15 | -$2.83M 10-Q · filed 2022-11-15 | -$3.59M derived: sum of 4 quarters · filed 2022-11-15 | ||||
| 2021-06-30 | -$1.12M 10-Q · filed 2022-08-15 | -$1.67M 10-Q · filed 2022-08-15 | -$2.42M derived: sum of 3 quarters · filed 2022-08-15 | -$3.43M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$543.00K 10-Q · filed 2022-05-05 | -$1.30M derived: sum of 2 quarters · filed 2022-05-05 | -$2.31M derived: sum of 3 quarters · filed 2022-05-05 | -$3.96M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$1.76M derived: sum of 2 quarters · filed 2022-03-03 | -$3.42M derived: sum of 3 quarters · filed 2022-03-03 | -$4.52M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | -$1.01M 10-Q · filed 2021-11-04 | -$1.07M 10-Q · filed 2020-11-05 | -$2.66M derived: sum of 2 quarters · filed 2021-11-04 | -$3.76M 10-Q · filed 2021-11-04 | -$3.94M 10-Q · filed 2020-11-05 | -$3.73M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$1.66M 10-Q · filed 2021-08-05 | -$1.72M 10-Q · filed 2020-08-05 | -$2.75M 10-Q · filed 2021-08-05 | -$2.87M 10-Q · filed 2020-08-05 | -$2.72M derived: sum of 3 quarters · filed 2021-08-05 | -$3.53M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$1.10M 10-Q · filed 2021-05-06 | -$1.16M 10-Q · filed 2020-05-06 | -$1.06M derived: sum of 2 quarters · filed 2021-05-06 | -$1.87M derived: sum of 3 quarters · filed 2021-05-06 | -$2.87M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$773.00K derived: sum of 2 quarters · filed 2021-03-01 | -$1.77M derived: sum of 3 quarters · filed 2021-03-01 | -$3.19M 10-K · filed 2021-03-01 | -$3.43M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$811.00K 10-Q · filed 2020-11-05 | -$1.81M derived: sum of 2 quarters · filed 2020-11-05 | -$3.22M 10-Q · filed 2020-11-05 | -$3.95M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$1.00M 10-Q · filed 2020-08-05 | -$2.41M 10-Q · filed 2020-08-05 | -$3.14M derived: sum of 3 quarters · filed 2020-08-05 | -$3.71M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$1.41M 10-Q · filed 2020-05-06 | -$2.14M derived: sum of 2 quarters · filed 2020-05-06 | -$2.71M derived: sum of 3 quarters · filed 2020-05-06 | -$3.39M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$727.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$1.29M derived: sum of 2 quarters · filed 2020-02-27 | -$1.98M derived: sum of 3 quarters · filed 2020-02-27 | -$3.41M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | -$567.00K 10-Q · filed 2019-11-06 | -$1.25M derived: sum of 2 quarters · filed 2019-11-06 | -$2.68M 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | -$688.00K 10-Q · filed 2019-08-07 | -$2.11M 10-Q · filed 2019-08-07 | ||||||
| 2018-03-31 | -$1.43M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |